Transcriptome Sequencing Identifies New Drug Targets in Prostate Cancer, Gastric Cancer, and Melanoma

A University of Michigan team identified gene fusions in the RAF kinase pathway in prostate cancer, gastric cancer, and melanoma. The researchers said the pathway could potentially be targeted by drugs that are currently in development.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.